Optimising the Management of Osteoporosis

Overview

Journal Clin Med (Lond)

Specialty General Medicine

Date 2020 Sep 16

PMID 32934064

Citations 12

Authors

Ziad Farrah

Ali Sm Jawad

Affiliations

Soon will be listed here.

Abstract

With increasing longevity of the population globally, the prevalence of osteoporosis will rise, associated with significant morbidity, disability and increased mortality. Adequate intake of calcium, vitamin D, increasing physical activity, a strategy of avoiding falls, cessation of smoking and avoiding excessive alcohol intake are pivotal in maintaining healthy bones in all age groups. Oral bisphosphonates remain the most cost-effective first line of treatment. Better methods of identifying patients with high fracture risk is needed as there is adequate effective treatment for osteoporosis.

Citing Articles

Prevalence of osteoporosis in the Iranian population: a systematic review and meta-analysis.

Fahimfar N, Hesari E, Mansourzadeh M, Khalagi K, Sanjari M, Hajivalizadeh S J Diabetes Metab Disord. 2024; 23(1):229-237.

PMID: 38932872 PMC: 11196456. DOI: 10.1007/s40200-023-01352-9.

Chloroform associated with bone mineral density and bone mineral content in adults: A population-based cross-sectional research.

Li L, Liu X, Zhang X, Zhang Y, Li Q, Geng H PLoS One. 2024; 19(3):e0290132.

PMID: 38427675 PMC: 10906833. DOI: 10.1371/journal.pone.0290132.

Weight change patterns across adulthood in relation to osteoporosis and fracture among non-obese individuals.

Jia P, Yuan J Arch Osteoporos. 2023; 19(1):2.

PMID: 38097861 DOI: 10.1007/s11657-023-01362-3.

Association between triglyceride-glucose index and bone mineral density in US adults: a cross sectional study.

Zhan H, Liu X, Piao S, Rong X, Guo J J Orthop Surg Res. 2023; 18(1):810.

PMID: 37904197 PMC: 10614394. DOI: 10.1186/s13018-023-04275-6.

Risk factors for osteoporosis among postmenopausal women in a Nigerian teaching hospital.

Ibrahim A, Sodipo O, Oduniyi O J Family Med Prim Care. 2023; 12(6):1145-1149.

PMID: 37636158 PMC: 10451596. DOI: 10.4103/jfmpc.jfmpc_2193_21.

References

Cauley J, Thompson D, Ensrud K, Scott J, Black D . Risk of mortality following clinical fractures. Osteoporos Int. 2000; 11(7):556-61. DOI: 10.1007/s001980070075. View

Boquete-Castro A, Gomez-Moreno G, Calvo-Guirado J, Aguilar-Salvatierra A, Delgado-Ruiz R . Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials. Clin Oral Implants Res. 2015; 27(3):367-75. DOI: 10.1111/clr.12556. View

Khosla S, Burr D, Cauley J, Dempster D, Ebeling P, Felsenberg D . Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007; 22(10):1479-91. DOI: 10.1359/jbmr.0707onj. View

Gourlay M, Fine J, Preisser J, May R, Li C, Lui L . Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med. 2012; 366(3):225-33. PMC: 3285114. DOI: 10.1056/NEJMoa1107142. View

Dennison E, Cooper C, Kanis J, Bruyere O, Silverman S, McCloskey E . Fracture risk following intermission of osteoporosis therapy. Osteoporos Int. 2019; 30(9):1733-1743. DOI: 10.1007/s00198-019-05002-w. View

Greenspan S, Myers E . Classification of osteoporosis in the elderly is dependent on site-specific analysis. Calcif Tissue Int. 1996; 58(6):409-14. DOI: 10.1007/BF02509439. View

Bischoff-Ferrari H, Dawson-Hughes B, Staehelin H, Orav J, Stuck A, Theiler R . Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009; 339:b3692. PMC: 2755728. DOI: 10.1136/bmj.b3692. View

Compston J . Osteoporosis. Clin Endocrinol (Oxf). 1990; 33(5):653-82. View

Zeytinoglu M, Jain R, Vokes T . Vertebral fracture assessment: Enhancing the diagnosis, prevention, and treatment of osteoporosis. Bone. 2017; 104:54-65. DOI: 10.1016/j.bone.2017.03.004. View

10.

Hernlund E, Svedbom A, Ivergard M, Compston J, Cooper C, Stenmark J . Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations.... Arch Osteoporos. 2013; 8:136. PMC: 3880487. DOI: 10.1007/s11657-013-0136-1. View

11.

Prince R, Sipos A, Hossain A, Syversen U, Ish-Shalom S, Marcinowska E . Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment. J Bone Miner Res. 2005; 20(9):1507-13. DOI: 10.1359/JBMR.050501. View

12.

Cummings S, Kiel D, Black D . Vitamin D Supplementation and Increased Risk of Falling: A Cautionary Tale of Vitamin Supplements Retold. JAMA Intern Med. 2016; 176(2):171-2. DOI: 10.1001/jamainternmed.2015.7568. View

13.

Curhan G, Willett W, Speizer F, Spiegelman D, Stampfer M . Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997; 126(7):497-504. DOI: 10.7326/0003-4819-126-7-199704010-00001. View

14.

. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994; 843:1-129. View

15.

Gordon C, Leonard M, Zemel B . 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom. 2014; 17(2):219-24. DOI: 10.1016/j.jocd.2014.01.007. View

16.

Tai V, Leung W, Grey A, Reid I, Bolland M . Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ. 2015; 351:h4183. PMC: 4784773. DOI: 10.1136/bmj.h4183. View

17.

Ross A, Manson J, Abrams S, Aloia J, Brannon P, Clinton S . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2010; 96(1):53-8. PMC: 3046611. DOI: 10.1210/jc.2010-2704. View

18.

Schilcher J, Koeppen V, Aspenberg P, Michaelsson K . Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014; 371(10):974-6. DOI: 10.1056/NEJMc1403799. View

19.

Black D, Delmas P, Eastell R, Reid I, Boonen S, Cauley J . Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007; 356(18):1809-22. DOI: 10.1056/NEJMoa067312. View

20.

McClung M, Geusens P, Miller P, Zippel H, Bensen W, Roux C . Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001; 344(5):333-40. DOI: 10.1056/NEJM200102013440503. View